- Home
- AZN vs ADI Comparison
AZN vs ADI Comparison
Compare AZN & ADI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AZN | ADI |
|---|---|---|
| Founded | 1992 | 1965 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.7B | 176.3B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | AZN | ADI |
|---|---|---|
| Price | $190.22 | $305.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 22 |
| Target Price | N/A | ★ $381.70 |
| AVG Volume (30 Days) | 1.8M | ★ 3.8M |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | ★ 1.66% | 1.43% |
| EPS Growth | N/A | ★ 39.02 |
| EPS | N/A | ★ 1.69 |
| Revenue | N/A | ★ $6,200,942,000.00 |
| Revenue This Year | $10.13 | $27.88 |
| Revenue Next Year | $6.21 | $9.86 |
| P/E Ratio | ★ $31.91 | $181.58 |
| Revenue Growth | N/A | ★ 21.41 |
| 52 Week Low | $61.24 | $158.65 |
| 52 Week High | $212.71 | $363.20 |
Technical Indicators
Market Signals| Indicator | AZN | ADI |
|---|---|---|
| Relative Strength Index (RSI) | 54.67 | 34.43 |
| Support Level | $89.28 | $223.69 |
| Resistance Level | $211.32 | $363.20 |
| Average True Range (ATR) | 3.22 | 8.36 |
| MACD | -5.15 | -6.17 |
| Stochastic Oscillator | 1.66 | 3.39 |
Price Performance
Historical ComparisonAbout AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
About ADI Analog Devices Inc.
Analog Devices is a leading analog, mixed-signal, and digital-signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers; more than half of its chip sales are to industrial and automotive end markets. ADI's chips are also incorporated into wireless infrastructure equipment.